ProFound Therapeutics Gains Up to $35M From Gates Foundation for Preeclampsia Discovery
ProFound Therapeutics received a Gates Foundation funding commitment of up to $35 million, including $20 million initially, to identify biomarkers, drug targets and potential protein therapeutics for preeclampsia and eclampsia. The program will combine…
